Immunicon and Ortho-Clinical Diagnostics collaborate

Immunicon (Huntingdon Valley, Penn.), which is developing cell-based drugs and diagnostics for cancer, and Ortho-Clinical Diagnostics, a subsidiary of Johnson & Johnson (JNJ), will develop and commercialize products for screening, diagnosis, monitoring of therapy and monitoring of disease recurrence in cancer. Immunicon will be responsible for product development, bulk reagent supply and manufacture of instrumentation systems, and Ortho-Clinical will be responsible for product finishing, sales and marketing. Immunicon will receive license and milestone payments plus a share of product revenues. ...